Gang Bao is a Respiratory physician. ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
6699 Alvarado Rd Ste 2306
San Diego, CA 921205241
Telephone
619-287-7617Registry record last updated 21 Dec 2018.
Clinical trials
- Surgical Treatment of Intra-spinal Canal Tumors Via Trans-Quadrant Channel
Sponsor: First Affiliated Hospital Xi'an Jiaotong University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
23 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Avadel CNS Pharmaceuticals, LLCProgram year20258 payments
- GlaxoSmithKline, LLC.Program year20258 payments
- JAZZ PHARMACEUTICALS INC.Program year20256 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
41.8%Corticosteroid30.9%Trelegy Ellipta67%Breztri Aerosphere33%Part D<11 patientsbeta2-Adrenergic Agonist10.9%Albuterol Sulfate Hfa100%Part D<11 patientsNervous system
35.8%Benzodiazepine related drugs13.9%Eszopiclone100%Part D<11 patientsgamma-Aminobutyric Acid A Receptor Agonist8.5%Zaleplon100%Part D<11 patients+ 2 more classes in this area
Anti-infectives
22.4%Macrolide Antimicrobial22.4%Azithromycin100%Part D≥11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Similar KOLs
Other experts from the same institution or the same specialty.
Tim Driscoll
The University of Sydney
Francesco Saverio Violante
IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola
Mark A. Rubin
University of Bern
Marc Humbert
Inserm
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”